Edwin O’Connor, a partner in Goodwin’s Life Sciences group, has a broad-based capital markets practice and represents issuers and underwriters in public and private corporate finance transactions, both in the United States and internationally. His experience encompasses initial public offerings, follow-on equity offerings, investment grade, high-yield and convertible debt offerings and offerings of preferred, hybrid and derivative securities. He has particular experience with capital markets transactions in the life sciences, tech and clean tech sectors.

Experience

ERFAHRUNG

EXPÉRIENCE

工作经历

Mr. O’Connor’s recent initial public offerings and follow-on offerings include:

  • Hillhouse Capital as lead investor in the $418 million private placement of I-Mab 
  • BeiGene in its $2.08 billion registered direct offering, $800 million, $201 million and $200 million follow-on offerings, and $158 initial public offering
  • argenx NV in its $862 million, $300 million and $266 million follow-on offerings, and $114 million initial public offering
  • BeiGene in its $2.7 billion global strategic collaboration with Amgen
  • Ascentage Pharma in its $53 million initial public offering on the Hong Kong Stock Exchange
  • Deciphera Pharmaceuticals in its $127 million initial public offering
  • Inotek Pharmaceuticals Corporation in its sale to Rocket Pharmaceuticals, $50 million offering of convertible senior notes, $69 million follow-on offering, $20 million offering of convertible senior notes, and $40 million initial public offering
  • Moderna in its $604 million initial public offering
  • Phreesia in its $167 million initial public offering
  • Voyager Therapeutics in its $70 million initial public offering
  • The underwriters in Albireo’s $160 million follow-on offering
  • The underwriters in Freeline Therapeutics’ $158 million initial public offering
  • The underwriters in Royalty Pharma’s $2.5 billion initial public offering
  • The underwriters in Syndax Pharmaceuticals’ $115 million follow-on offering
  • The underwriters in Centogene’s $56 million initial public offering
  • The underwriters in follow-on offerings for DBV Technologies
  • The underwriters in Genfit’s $135 million initial public offering
  • The underwriters in PhaseBio Pharmaceuticals’ $46 million initial public offering
  • The underwriters in Evelo Biosciences’ $85 million initial public offering
  • The underwriters in Arsanis’ $40 million initial public offering 
  • The underwriters in Altair Engineering’s $200 million convertible notes offering, $196 million follow-on offering and $156 million initial public offering
  • The underwriters in G1 Therapeutics’ $180 million and $100 million follow-on offerings, and $105 million initial public offering
  • The underwriters in Ovid Therapeutics’ $75 million initial public offering
  • The underwriter in BeyondSpring’s $54 million initial public offering
  • The underwriters in Reata Pharmaceuticals' $60.5 million initial public offering
  • The underwriters in Oncobiologics' $35 million initial public offering
  • The underwriters in Trinseo’s $190 million initial public offering*
  • The underwriters in Paycom Software’s $100 million initial public offering*

As Vice President in Goldman Sachs’ Investment Banking Division, Mr. O’Connor advised on several initial public offerings, including:

  • Cornerstone OnDemand’s $137 million initial public offering
  • RPX’s $160 million initial public offering
  • Gigamon’s $128.5 million initial public offering
  • Jive’s $120 million initial public offering
  • Palo Alto Network’s $260 million initial public offering

* Denotes experience prior to joining Goodwin.

Professional Experience

Prior to joining Goodwin in 2014, Mr. O’Connor practiced at Gibson, Dunn & Crutcher. Previously, he was a vice president in the Investment Banking Division of Goldman, Sachs & Co., where he was responsible for the execution of equity and equity-linked offerings across all industry sectors. While at Goldman, Mr. O’Connor was also a vice president, associate general counsel in the Investment Banking Division’s Legal Group. At Goldman, he worked on transactions occurring in a number of geographies, including New York, Silicon Valley, London and Hong Kong. Before joining Goldman, he was an associate at Davis Polk & Wardwell in New York and in London.

Recognition

In law school, Mr. O’Connor served as comments editor of The Journal of International Economic Law.

In The News

MELDUNGEN

ACTUALITÉS

相关新闻

Credentials

WERDEGANG

RÉFÉRENCES

专业资格

Education

J.D., 1998
University of Pennsylvania Law School
B.A., Economics, 1995
Colgate University
(magna cum laude; Phi Beta Kappa)

Admissions

Bar

New York
Profile Image
Get In Touch
Kontakt
NOUS CONTACTER
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
Recherche par Pratique
搜寻其他律师